Astra Industrial Group announces its Interim Financial Results for the Period Ending on 2023-09-30 ( Nine Months )

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	653,504,853	622,067,121	5.05	667,020,375	-2.03
Gross Profit (Loss)	261,097,570	219,942,168	18.71	277,971,966	-6.07
Operational Profit (Loss)	114,389,956	76,510,835	49.51	123,912,746	-7.68
Net Profit (Loss) after Zakat and Tax	103,415,243	70,865,145	45.93	114,744,049	-9.87
Total Comprehensive Income	108,008,769	70,989,680	52.15	103,628,214	4.23
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Sales/Revenue	2,068,803,343	1,865,130,534	10.92
Gross Profit (Loss)	851,042,731	719,580,291	18.27
Operational Profit (Loss)	377,086,671	263,217,470	43.26
Net Profit (Loss) after Zakat and Tax	341,043,859	388,651,783	-12.25
Total Comprehensive Income	341,972,773	383,941,378	-10.93
Total Share Holders Equity (after Deducting Minority Equity)	1,991,359,361	1,715,582,380	16.07
Profit (Loss) per Share	4.26	4.86
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit Increase in general due to:

1. Increase in sales and gross profit in pharmaceuticals sector.

2. Decrease in net financing cost in the other sector.The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is Net profit Decreases in general due to:

1. Decrease in Sales and Gross Profit in the following sectors:

a) Specialty chemical

b) Pharmaceuticals

While noting this was partially offset by increase in sales and gross profit in steel sector and other sector.

2. Increase in net financing cost in the specialty chemical sector.

3. Increase in provision for impairment of financial assets in pharmaceuticals sector.

While noting that there is a decrease in general and administrative expenses and selling and distribution expenses.The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is Net profit Decreases in general due to:

1. Similar period during last year included gain from discontinued operation.

2. Increase in general and administrative expenses in the following sectors:

a) Other

b) Specialty chemical

3. Increase in Zakat expenses in the following sectors:

a) Pharmaceuticals

b) Specialty chemical.

While noting the following:

1. Increase in sales and gross profit in the following sectors:

a) Pharmaceuticals

b) Steel industry

2. Decrease in net financing cost in the other sector.Statement of the type of external auditor's report Unmodified conclusionReclassification of Comparison Items NoneAdditional Information Net Shareholders’ Equity at the end of the period was SR 2,053,543,321/- compared to SR 1,714,921,175 /- at the end of the similar period last year with an increase of 20%.

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.